Rechercher

Pages

1. • Article de périodique

   • 

   Efficacy and toxicity of two schedules of bortezomib in patients with recurrent or refractory follicular lymphoma: A randomised phase II trial from the Groupe d'Etude des Lymphomes de l'Adulte (GELA)

   Ribrag, V. Tilly, H. Casasnovas, O. Bosly, André[UCL] Bouabdallah, R. Delarue, R. Boue, F. Bron, D. Feugier, P. Haioun, C. Offner, F. Coiffier, B. (2013) European Journal of Cancer — Vol. 49, no. 4, p. 904-910 (2013)
2. • Article de périodique

   • 

   Rituximab plus gemcitabine and oxaliplatin in patients with refractory/relapsed diffuse large B-cell lymphoma who are not candidates for high-dose therapy. A phase II lymphoma study Association trial

   Mounier, N. El Gnaoui, T. Tilly, H. Canioni, D. Sebban, C. Casasnovas, R.-O. Delarue, R. Sonet, Anne[UCL] Beaussart, P. Petrella, T. Castaigne, S. Bologna, S. Salles, G. Rahmouni, A. Gaulard, P. Haioun, C. (2013) Haematologica : journal of hematology — Vol. 98, no.11, p. 1726-1731 (2013)
3. • Article de périodique

   • 

   Prognostic-significance of Received Relative Dose Intensity in Non-hodgkins-lymphoma Patients - Application To Lnh-87 Protocol

   Lepage, E. Gisselbrecht, C. Haioun, C. Sebban, C. Tilly, H. Bosly, André[UCL] Morel, Priscilla[UCL] Herbrecht, R. Reyes, F. Coiffier, B. (1993) Annals of Oncology — Vol. 4, no. 8, p. 651-656 (1993)
4. • Article de périodique

   • 

   Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: Updated results of the prospective study LNH87-2

   Haioun, C. Lepage, E. Gisselbrecht, C. Bastion, Y. Coiffier, B. Brice, P. Bosly, André[UCL] Dupriez, B. Nouvel, C. Tilly, H. Lederlin, P. Biron, P. Briere, J Gaulard, P. Reyes, F. (1997) Journal of Clinical Oncology — Vol. 15, no. 3, p. 1131-1137 (1997)
5. • Article de périodique

   • 

   Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphomas

   Gisselbrecht, C. Gaulard, P. Lepage, E. Coiffier, B. Briere, J Haioun, C. Cazals-Hatem, D Bosly, André[UCL] Xerri, L Tilly, H. Berger, F. Bouhabdallah, R Diebold, J (1998) Blood — Vol. 92, no. 1, p. 76-82 (1998)
6. • Article de périodique

   • 

   Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin's lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: A GELA study on 974 patients

   Haioun, C. Besson, C Lepage, E. Thieblemont, C Simon, D Rose, C Tilly, H. Sonet, Anne Lederlin, P. Attal, M. Briere, J Reyes, F. (2000) Annals of Oncology — Vol. 11, no. 6, p. 685-690 (2000)
7. • Article de périodique

   • 

   Dose-dense rituximab-CHOP compared with standard rituximab-CHOP in elderly patients with diffuse large B-cell lymphoma (the LNH03-6B study): A randomised phase 3 trial

   Delarue, R. Tilly, H. Mounier, N. Petrella, T. Salles, G. Thieblemont, C. Bologna, S. Ghesquières, H. Hacini, M. Fruchart, C. Ysebaert, L. Fermé, C. Casasnovas, O. Van Hoof, A. Thyss, A. Delmer, A. Fitoussi, O. Molina, T.J. Haioun, C. Bosly, André[UCL] (2013) The Lancet Oncology — Vol. 14, no.6, p. 525-533 (2013)
8. • Communication

   • 

   Rituximab plus CHOP (R-CHOP) in the treatment of elderly patients with diffuse large B-cell lymphoma. An update of the GELA study.

   Coiffier, B. Ferme, C Hermine, O. Haioun, C. Baumelou, E Solal-Celigny, P. Delmer, A. Sebban, C. Mounier, N. Tertian, G Van Hoof, A. Bosly, André[UCL] (2001) —
9. • Communication

   • 

   Rituximab given after high dose therapy and autologous stem cell transplantation induces durable clearance of minimal residual disease in about half of the patients with follicular non Hodgkin's lymphoma: 36 months results of a multicenter open label phase II trial (M39012 trial).

   Morschhauser, F. Recher, C. Milpied, N. Gressin, R Salles, G. Brice, P. Vey, N Haioun, C. Colombat, P Bourhis, JH Rossi, JF Berriot-Varoqueaux, N Bergougnoux, L Bosly, André[UCL] Delsol, G. Attal, M. (2004) 46th Annual Meeting of the American-Society-of-Hematology — San Diego(Ca)
10. • Communication

    • 

    Superiority of late over early intensification in relapsing/refractory aggressive non-Hodgkin's lymphoma: A randomized study from the GELA: LNH RP 93

    Bosly, André[UCL] Ferrant, Augustin[UCL] Sonet, Anne Salles, G. Brice, P. Haioun, C. Kerneis, Y Tilly, H. Lederlin, P. Plantier, I Sebban, C. Gisselbrecht, C. Coiffier, B. (1998) —
11. • Article de périodique

    • 

    Long-term follow-up of an age-adapted C5R protocol followed by radiotherapy in 99 newly diagnosed primary CNS lymphomas: a prospective multicentric phase II study of the Groupe d'Etude des Lymphomes de l'Adulte (GELA)

    Ghesquieres, H. Van Den Neste, Eric[UCL] Ferlay, C. Sebban, C. Perol, D. Bosly, André[UCL] Casasnovas, O. Reman, O. Coiffier, B. Tilly, H. Morel, Priscilla[UCL] Colin, P. Haioun, C. Biron, P. Blay, J. -Y. (2010) Annals of Oncology — Vol. 21, no. 4, p. 842-50 (2010)
12. • Communication

    • 

    Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma (NHL) with the ACVBP regimen. A GELA (Groupe d'Etude des Lymphomes de l'Adulte) cohort study on 2849 patients.

    André, Marc Mounier, N. Leleu, X Sonet, Anne Brice, P. Tilly, H. Coiffier, B. Bosly, André[UCL] Morel, Priscilla[UCL] Haioun, C. Gaulard, P. Gisselbrecht, C. (2001) —
13. • Article de périodique

    • 

    Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: a GELA cohort study on 2837 patients

    André, Marc Mounier, N. Leleu, X Sonet, Anne Brice, P. Henry-Amar, M Tilly, H. Coiffier, B. Bosly, André[UCL] Morel, Priscilla[UCL] Haioun, C. Gaulard, P. Reyes, F. Gisselbrecht, C. (2004) Blood — Vol. 103, no. 4, p. 1222-1228 (2004)
14. • Article de périodique

    • 

    Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: Final analysis of the prospective LNH87-2 protocol - A Groupe d'Etude des Lymphomes de l'Adulte Study

    Haioun, C. Lepage, E. Gisselbrecht, C. Salles, G. Coiffier, B. Brice, P. Bosly, André[UCL] Morel, Priscilla[UCL] Nouvel, C. Tilly, H. Lederlin, P. Sebban, C. Briere, J Gaulard, P. Reyes, F. (2000) Journal of Clinical Oncology — Vol. 18, no. 16, p. 3025-3030 (2000)
15. • Communication

    • 

    Autologous Hematopoietic Stem-cell Transplantation in Intermediate and High-grade Non-hodgkins-lymphoma - a Review

    Gisselbrecht, C. Bosly, André[UCL] Lepage, E. Reyes, F. Philip, T. Haioun, C. Tilly, H. Coiffier, B. (1993) INTERNATIONAL CONSENSUS CONF ON INTENSIVE CHEMOTHERAPY PLUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MALIGNANCIES — LYON(France)
16. • Article de périodique

    • 

    High-dose treatment with autologous stem cell transplantation versus sequential chemotherapy: the GELA experience.

    Bosly, André[UCL] Haioun, C. Gisselbrecht, C. Reyes, F. Coiffier, B. (2001) European journal of haematology. Supplementum — Vol. 64, p. 3-7 (2001)
17. • Communication

    • 

    Late intensification is superior to early intensification in relapsing/refractory aggressive non-Hodgkin's lymphoma. A randomized study from the GELA: LNH RP93.

    Bosly, André[UCL] Sonet, Anne Salles, G. Brice, P. Haioun, C. Kerneis, Y Tilly, H. Lederlin, P. Plantier, I Sebban, C. Coiffier, B. (1997) —
18. • Article de périodique

    • 

    Recombinant Interferon-alfa-2b Combined With a Regimen Containing Doxorubicin in Patients With Advanced Follicular Lymphoma

    Solalceligny, P. Lepage, E. Brousse, N. Reyes, F. Haioun, C. Leporrier, M. Peuchmaur, M. Bosly, André[UCL] Parlier, Y. Brice, P. Coiffier, B. Gisselbrecht, C. (1993) New England Journal of Medicine — Vol. 329, no. 22, p. 1608-14 (1993)
19. • Communication

    • 

    High-dose therapy followed by stem cell transplantation in partial response after first-line induction therapy for aggressive non-Hodgkin's lymphoma

    Haioun, C. Lepage, E. Gisselbrecht, C. Coiffier, B. Doyen, Chantal Morel, Priscilla[UCL] Attal, M. Tilly, H. Deconinck, E Gaulard, P. Reyes, F. (1998) International Consensus Conference on High-Dose Therapy with Hematopoietic Stem Cell Transplantation in Diffuse Large-Cell Lymphoma — LYON(France)
20. • Communication

    • 

    Superiority of late over early intensification in relapsing/refractory aggressive non-Hodgkin's lymphoma: A randomized study from the GELA: LNH RP 93.

    Bosly, André[UCL] Ferrant, Augustin[UCL] Sonet, Anne Salles, G. Brice, P. Haioun, C. Kerneis, Y Tilly, H. Lederlin, P. Plantier, I Sebban, C. Gisselbrecht, C. Coiffier, B. (1998) —
21. • Communication

    • 

    Long Term Follow-up of the GELF86 French and Belgian Trials : Complete Remission after First Line Treatment with Conventional Chemotherapy in Newly Diagnosed Follicular Lymphoma Patients Correlates with Prolonged Overall Survival Compared with Partial Remission.

    Bachy, E. Brice, P. Fournier, M. Tilly, H. Haioun, C. Brousse, N. Le Gouil, S. Bosly, André[UCL] Coiffier, B. Gisselbrecht, C. Solal-Celigny, P. Salles, G. (2008) 50th Annual Meeting of the American- Society-of-Hematology — San Francisco(Ca)
22. • Communication

    • 

    Superiority of late over early intensification in relapsing/refractory aggressive non-Hodgkin's lymphoma: A randomized study from the GELA: LNH RP 93.

    Bosly, André[UCL] Sonet, Anne Salles, G. Brice, P. Haioun, C. Kerneis, Y Tilly, H. Lederlin, P. Plantier, I Sebban, C. Gisselbrecht, C. Coiffier, B. (1997) —
23. • Communication

    • 

    Ancestim (stem cell factor, SCF) in combination with filgrastim can mobilize sufficient peripheral blood progenitor cells (PBPC) to support high-dose salvage chemotherapy and late intensification in relapsing and refractory aggressive non-Hodgkin's lymphoma. A GELA study.

    Haioun, C. Ferrant, Augustin[UCL] Van Hoof, A. Thieblemont, C Hulin, C. Mounier, N. Tilly, H. Sebban, C. Allain, A Lepage, E. Osselaer, Jean-Claude[UCL] Beaujean, F Vannerom, H Cailliot, C Bosly, André[UCL] (2003) 45th Annual Meeting of the American-Society-of-Hematology — SAN DIEGO (California)
24. • Article de périodique

    • 

    A multivariate analysis of the survival of patients with aggressive lymphoma - Variations in the predictive value of prognostic factors during the course of the disease

    Mounier, N. Morel, Priscilla[UCL] Haioun, C. Coiffier, B. Tilly, H. Chatelain, Christian Lederlin, P. Thyss, A Herbrecht, R. Gisselbrecht, C. Lepage, E. (1998) Cancer — Vol. 82, no. 10, p. 1952-1962 (1998)
25. • Article de périodique

    • 

    Long-term follow-up of high-dose treatment with autologous haematopoietic progenitor cell support in 693 patients with follicular lymphoma: an EBMT registry study

    Montoto, S. Ferrant, Augustin[UCL] Canals, C. Rohatiner, A. Z. S. Taghipour, G. Sureda, A. Schmitz, N. Gisselbrecht, C. Fouillard, L. Milpied, N. Haioun, C. Slavin, S. Conde, E. Fruchart, C. Leblond, V. Tilly, H. Lister, T. A. Goldstone, A. H. (2007) Leukemia — Vol. 21, no. 11, p. 2324-2331 (2007)

Pages